Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / NGMDF - NuGen Medical Devices begins feasibility study in the Netherlands for InsuJet and Ozempic

NGMDF - NuGen Medical Devices begins feasibility study in the Netherlands for InsuJet and Ozempic

NuGen Medical Devices

(NewsDirect)

NuGen Medical Devices executive chairmanTony Di Benedetto joined Steve Darling from Proactive to providedetails about the company that is developing the next generation ofneedle-free technologies for both humans and animals.

DiBenedetto shares with Proactive more about the technology behindproducts InsuJet and PetJet and also about an assessment andfeasibility study in the Netherlands of InsuJet for Semaglutide or itsmore widely known name Ozempic.

ContactDetails

Proactive Investors

+1 604-688-8158

na-editorial@proactiveinvestors.com

Copyright (c) 2023 TheNewswire - All rights reserved.

Stock Information
Company Name: NuGen Medical Devices
Stock Symbol: NGMDF
Market: OTC
Website: nugenmd.com
Menu
NGMDF NGMDF Quote NGMDF Short NGMDF News NGMDF Articles NGMDF Message Board
Get NGMDF Alerts

News, Short Squeeze, Breakout and More Instantly...